Trials / Completed
CompletedNCT00294619
Treatment of Adults With Growth Hormone Deficiency
A Phase III, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Study to Assess Efficacy and Safety of LB03002 Administered Weekly in Adults With Growth Hormone Deficiency.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 147 (actual)
- Sponsor
- LG Life Sciences · Industry
- Sex
- All
- Age
- 23 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate efficacy and safety profile of a new weekly administered growth hormone preparation compared with placebo in adults with growth hormone deficiency.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | growth hormone | subcutaneous injection, once-weekly |
Timeline
- Start date
- 2006-04-01
- Primary completion
- 2008-03-01
- Completion
- 2008-03-01
- First posted
- 2006-02-22
- Last updated
- 2012-10-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00294619. Inclusion in this directory is not an endorsement.